Connect with us

National

What are the risks associated with human challenge trials for SARS-CoV-2 vaccine candidates? – News-Medical.Net

Researchers from the University of Haifa, Israel, and WAW Statistical Consulting Ltd, UK, designed a model that helps determine the risks faced by participants…

Published

on

The timely development of preventive vaccines and new therapeutic drugs will be crucial in managing the burden caused by the coronavirus disease 2019 (COVID-19) pandemic. While there are no approved vaccines for COVID-19 currently, as per estimates, global vaccine production will reach 8 billion doses by 2021, assuming the best vaccine candidate passes clinical trials as expected.
Traditional clinical trials are time-consuming and need a large number of subjects to detect the therapeutic effects…

Click here to view the original article.